Device Trial Radar · NCT04630626
Post-Approval Study Protocol for the Simplify Cervical Artificial Disc
Last checked: Nov 19, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
145
Actual
Start
Jan 1, 2021
Primary completion
Apr 23, 2023
Study completion Apr 23, 2023
Sponsor
- Lead sponsor
- NuVasiveNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 16, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized Simplify Disc IDE study. This study was conducted under IDE G140154.
Conditions
- Cervical Degenerative Disc Disorder
Interventions
Simplify DiscDevice
The Simplify Disc is a cervical artificial disc manufactured from polyether ether ketone (PEEK) endplates and a mobile, zirconia-toughened alumina ceramic core.
ACDFOther
Historical ACDF control data
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinical Composite Success, Parent IDE Study + Post Approval Study (PAS)Time frame: IDE study 24 months + PAS 36 months = 60 months total
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Orthopaedic Education and Research Institute of Southern California
Orange, California
USCD
San Diego, California
The Spine Institute for Spine Restoration
Santa Monica, California
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.